The Ending the HIV Epidemic (EtHE) initiative targets a 75% decline in HIV incidence in 5 years and a 90% decline in 10 years. Currently HIV incidence in the U.S are derived from the Center for Disease Control’s CD4 depletion model. The EtHE initiative requires an understanding of HIV incidence at a regional and local level to evaluate the impact of prevention interventions. Here we examine the accuracy of the CD4 depletion model for measuring incidence in sub-epidemics.
Using the San Diego Primary Infection Resource Consortium estimated date of infection (PIRC EDI) model as a gold standard (a model that estimates recency using the limiting-antigen [LAg] avidity assay in combination with viral load information which has an estimated false recency rate of 1%), we found that the sensitivity of the CD4 model was 51% (95% CI 47%-55%) and specificity was 60% (95% CI 52%-67%) (see abstract 1291). We used this to calculate the predictive values of CD4 recency testing in various epidemic scenarios.
Using the above estimates, we calculated the positive predictive value (PPV), negative predictive value (NPV), and the posterior odds (PO), for various proportions of incident infections, ranging from 5% to 50%, in a setting of 1000 newly diagnosed infections. For a test on a single individual, PPV ranged from 6.3% to 56.0%, NPV ranged from 95.9% to 55.1%, and PO from 0.67 to 1.28. Using a fixed proportion of 25% incident infections among all new diagnoses, we varied the size of the sampled population from 250 to 10,000 to evaluate the accuracy of the CD4 model in predicting the number of incident cases in different size epidemics. The estimated values were approximately 1.7 fold greater, ranging from 106.8 (95% CI 105.5 to 135.3) incident infections (true value 62.5) for a population of 250, to 4275 (95% CI 3850 to 4775) incident infections for a population of 10000 (true value 2500).
Although the CD4 model is not designed to predict if an infection is incident at an individual test level, the uncertainty in this test also impacts population scale estimates. As interventions to prevent HIV transmission are scaled up as part of the EtHE effort, we need more accurate estimates of incidence that can be applied at smaller population scales, so that we will be able to measure the impact of our outcomes.